Nykaa's Hot Pink Sale offering up to 50% off went live today, on July 25. The sale will be live till July 31, 2022. This sale brings limited-time offers and deals on multiple beauty and makeup products, including top eyeliners. We have listed six of the best eyeliners that you can buy now under Rs. 299.
1. Lakme Insta Liner - Black
Price: Rs. 117 | 10% Off
This Lakme eyeliner is a water-resistant, non-organic eyeliner. It is easy to apply and also dries fast. This eyeliner can help you define the outline of your eyes and is perfect for daily wear.
2. Maybelline New York Colossal Bold Eyeliner - Black
Price: Rs. 149 | 40% Off
Maybelline New York Colossal Bold Eyeliner is waterproof, smudge-proof, and bold with intense formula. It is perfect for all winged liner styles including the long line liner look, thick winged eyeliner, and more. This eyeliner glides like liquid on the eyes and dries in a few seconds.
3. Nykaa Black Magic Liquid Eyeliner - Super Black
Price: Rs. 254 | 15% Off
Nykaa's Black Magic Liquid Eyeliner features melt, crack, and run-resistant properties.
It claims to be entirely smudge-proof, highly pigmented, and water resistant. The brush can glide smoothly and is simple to use.
4. Lakme Absolute Shine Liquid Liner - Black
Price: Rs. 248 | 45% Off
The matte, jet-black Lakme Absolute Shine Liquid Liner features a vibrant colour payoff. You can apply it without the hassle and it lasts for a long time. It is the perfect product for someone who is a beginner at makeup.
5. Maybelline New York The Colossal Liner - Black
Price: Rs. 294 | 30% Off
Maybelline New York The Colossal Liner has quick application features. It is supposed to provide a 12-hour long-lasting finish and dries quickly after application. The flexible tip of the liner is intended to minimize application errors and glides easily to provide a tidy, attractive finish.
For more such stories, stay tuned to HerZindagi.
Take charge of your wellness journey—download the HerZindagi app for daily updates on fitness, beauty, and a healthy lifestyle!
Comments
All Comments (0)
Join the conversation